Stock Track | Edgewise Therapeutics Plummets 5.19% Intraday Following Q4 Earnings Miss and Inducement Grants
Stock Track
Mar 02
Edgewise Therapeutics, Inc. (EWTX) experienced a sharp decline of 5.19% during Monday's intraday session, as the stock reacted negatively to recent corporate announcements.
The primary driver appears to be the company's fourth-quarter earnings report, which revealed an adjusted loss per share of $0.47. This result fell short of the average analyst estimate, which anticipated a loss of $0.44 per share. The company reported a quarterly loss of $50.22 million.
Concurrently, Edgewise Therapeutics disclosed the granting of inducement stock options covering 51,000 shares to three new non-executive employees. While a routine corporate action, the news may have contributed to investor sentiment amid the disappointing earnings results.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.